SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 3, 2004
| | | |
GUILFORD PHARMACEUTICALS INC.
|
(Exact name of registrant as specified in its
charter) |
| |
| | | | | |
Delaware
| | 0-23736
| | 52-1841960
|
(State or other jurisdiction of
incorporation or organization) | | (Commission File
Number) | | (I.R.S. Employer
Identification No.) |
| |
| | | |
| 6611 Tributary Street | | |
Baltimore, Maryland
| | 21224
|
| (Address of principal executive offices) | | (Zip Code) |
| |
Registrant’s telephone number, including area code: (410) 631-6300
| | | |
|
| (Former name or former address, if changed since last report) |
| |
-1-
INFORMATION TO BE INCLUDED IN THE REPORT
| | | |
Item 5. | | Other Events. |
| | | |
| | On May 3, 2004, the Company issued a press release announcing the resignation of Andrew R. Jordan, Executive Vice President, Finance and Administration and Chief Financial Officer, effective May 31st. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. |
| | | |
Item 7. | | Financial Statements, Pro Forma Financial Information and Exhibits |
| | | |
| | | (c) Exhibits |
| | | |
| 99.1 | | Press Release of Guilford Pharmaceuticals Inc. issued May 3, 2004 |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Guilford Pharmaceuticals Inc. |
| | | | | |
| Date: May 5, 2004 | | By: | | /s/ Asher M. Rubin
Asher M. Rubin
Vice President, General Counsel
and Secretary |
-3-
INDEX TO EXHIBITS
| | | | | |
| Exhibit | | | | |
| Number | | Exhibit Description | | Page |
|
| |
| 99.1 | | Press Release dated May 3, 2004 | | 5 |
-4-
